Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, 60 Degrees Pharmaceuticals Inc’s stock clocked out at $0.22, up 8.54% from its previous closing price of $0.20. In other words, the price has increased by $8.54 from its previous closing price. On the day, 0.77 million shares were traded. SXTP stock price reached its highest trading level at $0.2352 during the session, while it also had its lowest trading level at $0.202.
Ratios:
To gain a deeper understanding of SXTP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 31 ’24 when XU CHERYL bought 200,000 shares for $0.38 per share. The transaction valued at 75,000 led to the insider holds 424,934 shares of the business.
DOW GEOFFREY S bought 25,974 shares of SXTP for $9,740 on Jan 31 ’24. The President and CEO now owns 703,599 shares after completing the transaction at $0.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTP now has a Market Capitalization of 2530490 and an Enterprise Value of 10147661. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.12. Its current Enterprise Value per Revenue stands at 40.019 whereas that against EBITDA is -1.988.
Stock Price History:
Over the past 52 weeks, SXTP has reached a high of $8.65, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -15.83%, while the 200-Day Moving Average is calculated to be -71.24%.
Shares Statistics:
It appears that SXTP traded 220.49K shares on average per day over the past three months and 274820 shares per day over the past ten days. A total of 11.57M shares are outstanding, with a floating share count of 8.73M. Insiders hold about 24.51% of the company’s shares, while institutions hold 3.35% stake in the company. Shares short for SXTP as of 1713139200 were 130701 with a Short Ratio of 0.59, compared to 1710460800 on 65496. Therefore, it implies a Short% of Shares Outstanding of 130701 and a Short% of Float of 1.24.
Earnings Estimates
The dynamic stock of 60 Degrees Pharmaceuticals Inc (SXTP) is currently being evaluated by a team of 2 analysts, each contributing to its current rating.On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.16, while EPS last year was $0.77. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.07 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.29 and -$0.44 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.26, with 2.0 analysts recommending between -$0.12 and -$0.41.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $240k. There is a high estimate of $280k for the next quarter, whereas the lowest estimate is $200k.
A total of 2 analysts have provided revenue estimates for SXTP’s current fiscal year. The highest revenue estimate was $1.27M, while the lowest revenue estimate was $800k, resulting in an average revenue estimate of $1.03M. In the same quarter a year ago, actual revenue was $254kBased on 2 analysts’ estimates, the company’s revenue will be $2.95M in the next fiscal year. The high estimate is $3.8M and the low estimate is $2.1M.
